Stocktoria
Praxis Precision Medicines, Inc. PRAX
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2020-10-16
Praxis Precision Medicines, Inc. statistics & valuation
Market cap$9.1B
P / B10.4×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | — | -2340.3% | -5164.4% | — | — |
| Net margin | — | -2137.5% | -5037.9% | — | — |
| FCF margin | — | -1540.5% | -4543.8% | — | — |
| Return on assets | -32.3% | -37.8% | -140.2% | -185.9% | -57.1% |
| Return on equity | -34.5% | -41.0% | -176.9% | -281.2% | -66.6% |
| Current ratio | 10.22 | 10.77 | 5.39 | 3.23 | 7.48 |
| Revenue growth | -100.0% | 249.5% | — | — | — |
Source: SEC EDGAR filings · CIK 0001689548 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.